Forbes |
J&J Drug Prevents Heart Attacks At Cost Of Amputated Toes
Forbes Invokana, a diabetes drug made by Johnson & Johnson, decreases the risk of heart attacks and strokes, but also increases the risk of amputation, particularly of toes. The result is a blow to J&J, and a boost to rivals Eli Lilly and Boehringer Ingelheim ... CANVAS: Canagliflozin Reduces CV Events, but at Cost of Amputations J&J's Invokana matches Jardiance's 14% reduction in major CV events—but doubles amputation risk, too Canagliflozin reduces risk for CVD, kidney disease in patients with type 2 diabetes |
from Health - Google News http://ift.tt/2s4smNb
EmoticonEmoticon